Оценка эффективности антитромбоцитарной терапии у пациентов с коронарным атеросклерозом по показателям спонтанной агрегации тромбоцитов
Усачева Елена Владимировна, Бунова Светлана Сергеевна, Н. Л. Заворотняя et al. · Сибирский медицинский журнал (Иркутск) · 2013
A study was conducted in 212 patients at the age of 31 to 73 years. They had coronary heart disease and heart attack or coronary intervention in their past. The effectiveness of antiagregation therapy was determined. It has been established that among the patients, who receive acetylsalicylic acid, there are signs of hiperagregation in spontaneous platelet aggregation in 76% of cases. The patients receiving combination therapy – acetylsalicylic acid blocker + ADP-receptor inhibitors – ticagrelor (1,33 standard units, p
Cited by 0 works.